Meftinib 250mg Tablet

Introduction to Meftinib 250mg Tablet

Meftinib 250mg Tablet is a medication primarily used to treat a specific type of lung cancer known as non-small cell lung cancer (NSCLC). It is particularly effective for patients with certain genetic mutations in their cancer cells.

Composition of Meftinib 250mg Tablet

The active ingredient in Meftinib 250mg Tablet is Gefitinib, which is a type of drug known as an EGFR tyrosine kinase inhibitor. This means it targets specific proteins in cancer cells to stop their growth.

Uses of Meftinib 250mg Tablet

• Treatment of locally advanced or metastatic non-small cell lung cancer (NSCLC).
• Specifically prescribed for patients with EGFR mutations.
• Used in patients who have not received prior chemotherapy.

Side effects of Meftinib 250mg Tablet

Common side effects:

• Diarrhea
• Skin rash
• Nausea
• Vomiting
• Loss of appetite

Serious side effects:

• Liver toxicity
• Lung inflammation
• Severe diarrhea leading to dehydration

Precautions of Meftinib 250mg Tablet

Meftinib should not be used by individuals without EGFR mutations. It is also contraindicated for pregnant or breastfeeding women, those with severe liver or kidney disease, and individuals with a history of interstitial lung disease. Patients allergic to Gefitinib or any of its ingredients should avoid this medication.

How to Take Meftinib 250mg Tablet

• Take one tablet orally once daily.
• It is best to take it at the same time each day.
• Swallow the tablet whole with water.
• Can be taken with or without food.

Conclusion of Meftinib 250mg Tablet

Meftinib 250mg Tablet is a targeted therapy for certain types of lung cancer, offering hope to patients with specific genetic profiles. As with any medication, it is important to follow your healthcare provider's instructions and report any side effects promptly.